BDBM50428706 CHEMBL2333138::US9884828, 2-136

SMILES NC(=O)c1nnc2cc(ccc2c1NCCCO)-c1ccncc1

InChI Key InChIKey=YAGKSVSVQYJXKY-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50428706   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Imago Pharmaceuticals

US Patent
LigandPNGBDBM50428706(CHEMBL2333138 | US9884828, 2-136)
Affinity DataIC50:  120nMpH: 7.5 T: 2°CAssay Description:Compounds as described herein (compounds of Formula I, e.g., compounds of the above Examples) are tested for their in vitro kinase activities using v...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Imago Pharmaceuticals

US Patent
LigandPNGBDBM50428706(CHEMBL2333138 | US9884828, 2-136)
Affinity DataIC50:  121nMAssay Description:Inhibition of wild type GST-tagged LRRK2 (970 to 2527 amino acid residues) (unknown origin) assessed as inhibition of biotinylated-LRRKtide phosphory...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed